These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17702622)

  • 21. Microalbuminuria as an early marker for cardiovascular disease.
    de Zeeuw D; Parving HH; Henning RH
    J Am Soc Nephrol; 2006 Aug; 17(8):2100-5. PubMed ID: 16825327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAIT-survey-Prevalence of albuminuria in patients with diabetes and hypertension in Turkey.
    Fici F; Bakir EA; Beyaz S; Makel W; Robles NR
    Prim Care Diabetes; 2018 Dec; 12(6):558-564. PubMed ID: 30327190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of microalbuminuria as a cardiovascular risk indicator: A review.
    Diercks GF; van Boven AJ; Hillege JL; de Jong PE; Rouleau JL; van Gilst WH
    Can J Cardiol; 2002 May; 18(5):525-35. PubMed ID: 12032579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of urinary albumin excretion in arterial hypertension].
    de la Sierra A; Divisón JA; Garrido P; Barbón A; Arístegui R;
    Rev Clin Esp; 2012 Apr; 212(4):172-8. PubMed ID: 22176929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microalbuminuria screening in patients with hypertension: recommendations for clinical practice.
    Volpe M
    Int J Clin Pract; 2008 Jan; 62(1):97-108. PubMed ID: 17971155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases.
    Klausen KP; Scharling H; Jensen JS
    J Intern Med; 2006 Sep; 260(3):231-7. PubMed ID: 16918820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microalbuminuria: what is it? Why is it important? What should be done about it?
    Bakris GL
    J Clin Hypertens (Greenwich); 2001; 3(2):99-102. PubMed ID: 11416691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring and managing urinary albumin excretion: practical advice for primary care clinicians.
    Bakris GL; Kuritzky L
    Postgrad Med; 2009 Jul; 121(4):51-60. PubMed ID: 19641270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microalbuminuria and cardiorenal risk: old and new evidence in different populations.
    Márquez DF; Ruiz-Hurtado G; Segura J; Ruilope L
    F1000Res; 2019; 8():. PubMed ID: 31583081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers.
    Nosadini R; Tonolo G
    J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of hyperglycemia on urinary albumin excretion in recent onset diabetes mellitus type II.
    Nikolaidou B; Gkaliagkousi E; Anyfanti P; Gavriilaki E; Lazaridis A; Triantafyllou A; Zografou I; Douma S
    BMC Nephrol; 2020 Apr; 21(1):119. PubMed ID: 32252655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microalbuminuria in essential hypertension.
    Crippa G
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S74-7. PubMed ID: 11986900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors that predict development of microalbuminuria in treated hypertensive men. The Risk Factor Intervention Study Group.
    Agewall S; Fagerberg B
    Angiology; 1996 Oct; 47(10):963-72. PubMed ID: 8873582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.
    Mogensen CE
    J Intern Med; 2003 Jul; 254(1):45-66. PubMed ID: 12823642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
    Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microalbuminuria and hypertension.
    Reboldi G; Gentile G; Angeli F; Verdecchia P
    Minerva Med; 2005 Aug; 96(4):261-75. PubMed ID: 16179893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Indian Guideline 2024 by Association of Physicians of India and Indian College of Physicians.
    Wander GS; Panda JK; Pal J; Mathur G; Sahay R; Tiwaskar M; Chatterjee N; Chakrabarty S; Singh DP; Murthy LS; Ghosh S; Samajdar SS; Maheswari S
    J Assoc Physicians India; 2024 Aug; 72(8):e1-e25. PubMed ID: 39163066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study.
    McQueen MJ; Gerstein HC; Pogue J; Mann JF; Yusuf S
    Am J Kidney Dis; 2006 Dec; 48(6):889-96. PubMed ID: 17162143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.